» Articles » PMID: 35887527

Machine-Learning Algorithm for Predicting Fatty Liver Disease in a Taiwanese Population

Overview
Journal J Pers Med
Date 2022 Jul 27
PMID 35887527
Authors
Affiliations
Soon will be listed here.
Abstract

The rising incidence of fatty liver disease (FLD) poses a health challenge, and is expected to be the leading global cause of liver-related morbidity and mortality in the near future. Early case identification is crucial for disease intervention. A retrospective cross-sectional study was performed on 31,930 Taiwanese subjects (25,544 training and 6386 testing sets) who had received health check-ups and abdominal ultrasounds in Changhua Christian Hospital from January 2009 to January 2019. Clinical and laboratory factors were included for analysis by different machine-learning algorithms. In addition, the performance of the machine-learning algorithms was compared with that of the fatty liver index (FLI). Totally, 6658/25,544 (26.1%) and 1647/6386 (25.8%) subjects had moderate-to-severe liver disease in the training and testing sets, respectively. Five machine-learning models were examined and demonstrated exemplary performance in predicting FLD. Among these models, the xgBoost model revealed the highest area under the receiver operating characteristic (AUROC) (0.882), accuracy (0.833), F1 score (0.829), sensitivity (0.833), and specificity (0.683) compared with those of neural network, logistic regression, random forest, and support vector machine-learning models. The xgBoost, neural network, and logistic regression models had a significantly higher AUROC than that of FLI. Body mass index was the most important feature to predict FLD according to the feature ranking scores. The xgBoost model had the best overall prediction ability for diagnosing FLD in our study. Machine-learning algorithms provide considerable benefits for screening candidates with FLD.

Citing Articles

Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis.

Tudor M, Gheorman V, Simeanu G, Dobrinescu A, Padureanu V, Dinescu V Metabolites. 2024; 14(4).

PMID: 38668326 PMC: 11052048. DOI: 10.3390/metabo14040198.


Metabolic Dysfunction-Associated Fatty Liver Disease in Taiwanese Patients with Inflammatory Bowel Disease: A Study in Patients with Clinical Remission.

Hsiao S, Chen T, Su P, Yang C, Huang S, Chen Y Diagnostics (Basel). 2023; 13(20).

PMID: 37892089 PMC: 10606634. DOI: 10.3390/diagnostics13203268.


Comparison of Machine Learning Models and the Fatty Liver Index in Predicting Lean Fatty Liver.

Su P, Chen Y, Lin C, Su W, Huang S, Yen H Diagnostics (Basel). 2023; 13(8).

PMID: 37189508 PMC: 10137474. DOI: 10.3390/diagnostics13081407.


Prediction of Fatty Liver Disease in a Chinese Population Using Machine-Learning Algorithms.

Weng S, Hu D, Chen J, Yang Y, Peng D Diagnostics (Basel). 2023; 13(6).

PMID: 36980476 PMC: 10047083. DOI: 10.3390/diagnostics13061168.

References
1.
Yen H, Wu P, Chen M, Lin W, Tsai C, Lin K . Current Status and Future Perspective of Artificial Intelligence in the Management of Peptic Ulcer Bleeding: A Review of Recent Literature. J Clin Med. 2021; 10(16). PMC: 8397124. DOI: 10.3390/jcm10163527. View

2.
Lin Y, Lin C, Wang S, Lin S, Chang S . Noninvasive and Convenient Screening of Metabolic Syndrome Using the Controlled Attenuation Parameter Technology: An Evaluation Based on Self-Paid Health Examination Participants. J Clin Med. 2019; 8(11). PMC: 6912761. DOI: 10.3390/jcm8111775. View

3.
Procino F, Misciagna G, Veronese N, Caruso M, Chiloiro M, Cisternino A . Reducing NAFLD-screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans. Liver Int. 2018; 39(1):187-196. DOI: 10.1111/liv.13970. View

4.
Chalasani N, Younossi Z, Lavine J, Charlton M, Cusi K, Rinella M . The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2017; 67(1):328-357. DOI: 10.1002/hep.29367. View

5.
Arieira C, Monteiro S, Xavier S, Dias de Castro F, Magalhaes J, Moreira M . Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the difference. Eur J Gastroenterol Hepatol. 2019; 31(8):998-1003. DOI: 10.1097/MEG.0000000000001319. View